pI: 5.199 |
Length (AA): 245 |
MW (Da): 27135 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
3 | 242 | 1bd0 (A) | 5 | 231 | 16.00 | 0 | 1 | 1.17 | -0.38 |
6 | 237 | 1ct5 (A) | 6 | 246 | 42.00 | 0 | 1 | 1.49 | -1.46 |
6 | 239 | 3r79 (A) | 2 | 220 | 35.00 | 0 | 1 | 1.4221 | -0.84 |
13 | 237 | 1ct5 (A) | 13 | 246 | 44.00 | 0 | 1 | 1.55637 | -1.76 |
26 | 239 | 3r79 (A) | 18 | 220 | 45.00 | 0 | 1 | 1.37667 | -0.6 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_127174)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G26860 | putative pyridoxal phosphate-dependent enzyme, YBL036C type |
Arabidopsis thaliana | AT1G11930 | putative pyridoxal phosphate-dependent enzyme, YBL036C type |
Brugia malayi | Bm1_39750 | Hypothetical UPF0001 protein F09E5.8 in chromosome II, putative |
Candida albicans | CaO19.2794 | similar to family of uncharacterized enzymes that bind to pyridoxal-5'-phosphate. |
Candida albicans | CaO19.10312 | similar to family of uncharacterized enzymes that bind to pyridoxal-5'-phosphate. |
Caenorhabditis elegans | CELE_F09E5.7 | Protein F09E5.7 |
Caenorhabditis elegans | CELE_F09E5.8 | Protein F09E5.8 |
Cryptosporidium hominis | Chro.50329 | hypothetical protein |
Cryptosporidium parvum | cgd5_620 | conserved hypothetical protein |
Dictyostelium discoideum | DDB_G0278713 | alanine racemase N-terminal domain-containing protein |
Drosophila melanogaster | Dmel_CG1983 | CG1983 gene product from transcript CG1983-RB |
Escherichia coli | b2951 | UPF0001 family protein, PLP-binding |
Echinococcus granulosus | EgrG_001049210 | proline synthetase co transcribed protein |
Entamoeba histolytica | EHI_188790 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_001049210 | proline synthase co transcribed bacterial |
Giardia lamblia | GL50803_15041 | Hypothetical protein, enzyme with a TIM-barrel fold |
Homo sapiens | ENSG00000147471 | proline synthetase co-transcribed homolog (bacterial) |
Leishmania braziliensis | LbrM.23.1720 | alanine racemase, putative;with=GeneDB:LmjF23.1480 |
Leishmania donovani | LdBPK_231880.1 | alanine racemase, putative |
Leishmania infantum | LinJ.23.1880 | alanine racemase, putative;with=GeneDB:LmjF23.1480 |
Leishmania major | LmjF.23.1480 | alanine racemase, putative |
Leishmania mexicana | LmxM.23.1480 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_00735 | hypothetical protein |
Mycobacterium leprae | ML0919 | CONSERVED HYPOTHETICAL PROTEIN |
Mus musculus | ENSMUSG00000031485 | proline synthetase co-transcribed |
Mycobacterium tuberculosis | Rv2148c | Conserved protein |
Mycobacterium ulcerans | MUL_3496 | hypothetical protein |
Neospora caninum | NCLIV_010840 | hypothetical protein |
Oryza sativa | 4337823 | Os05g0150000 |
Onchocerca volvulus | OVOC5074 | Proline synthase homolog |
Plasmodium berghei | PBANKA_0820600 | pyridoxal 5'-phosphate dependent enzyme class III, putative |
Plasmodium falciparum | PF3D7_0919700 | pyridoxal 5'-phosphate dependent enzyme class III, putative |
Plasmodium knowlesi | PKNH_0717700 | pyridoxal 5'-phosphate dependent enzyme class III, putative |
Plasmodium vivax | PVX_099400 | hypothetical protein, conserved |
Saccharomyces cerevisiae | YBL036C | hypothetical protein |
Schistosoma japonicum | Sjp_0212560 | ko:K06997 PROSC, LOC482854; proline synthetase co-transcribed homolog (bacterial), putative |
Schistosoma mansoni | Smp_070810 | proline synthetase associated protein |
Schmidtea mediterranea | mk4.006372.00 | Proline synthase co-transcribed bacterial homolog protein |
Schmidtea mediterranea | mk4.035922.03 | |
Trypanosoma brucei gambiense | Tbg972.5.1770 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.5.1280 | alanine racemase, putative |
Trypanosoma congolense | TcIL3000_5_1300 | alanine racemase, putative |
Trypanosoma congolense | TcIL3000_0_42700 | alanine racemase, putative |
Trypanosoma cruzi | TcCLB.509767.90 | alanine racemase, putative |
Trypanosoma cruzi | TcCLB.509601.90 | alanine racemase, putative |
Toxoplasma gondii | TGME49_318720 | pyridoxal phosphate enzyme, YggS family protein |
Theileria parva | TP02_0565 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_043550 | proline synthetase associated protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu2181 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb927.5.1280 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.5.1280 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.5.1280 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.5.1280 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b2951 | Escherichia coli | non-essential | goodall |
CELE_F09E5.8 | Caenorhabditis elegans | embryonic lethal | wormbase |
TGME49_318720 | Toxoplasma gondii | Essentiality uncertain | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
catalytic activity (GO:0003824) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania amazonensis | No drug identifiers listed for this gene. | |
Annotator: | crowther@u.washington.edu. | Comment: | Drug: D-cycloserine. chemical inhibitors reduce alanine racemase activity. | References: | 16487314 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.